CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox.ARC ...
Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared ...
Nanox partners with Keiser University to deploy advanced imaging technology, enhancing education while improving diagnostic accuracy and reducing radiation exposure. NANO-X IMAGING LTD announced a ...
Nanox.ARC presents high powered digital X-ray tubes for 3D tomosynthesis imaging Nanox.ARC could help expand the availability of medical imaging NEVE ILAN, Israel, May 01, 2023 (GLOBE NEWSWIRE) -- ...
First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications Enhanced imaging system features ...
AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox’s artificial intelligence solutions in operations PETAH TIKVA, Israel, ...
The medical imaging technology company markets X-ray equipment powered by a low-voltage source of electrons. Traditional X-ray tubes use superheated filaments that require a lot more maintenance than ...
PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback